142 related articles for article (PubMed ID: 9748471)
1. Structure-function relationships in the ezrin family and the effect of tumor-associated point mutations in neurofibromatosis 2 protein.
Turunen O; Sainio M; Jääskeläinen J; Carpén O; Vaheri A
Biochim Biophys Acta; 1998 Sep; 1387(1-2):1-16. PubMed ID: 9748471
[TBL] [Abstract][Full Text] [Related]
2. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
3. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
[TBL] [Abstract][Full Text] [Related]
4. Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.
Nguyen R; Reczek D; Bretscher A
J Biol Chem; 2001 Mar; 276(10):7621-9. PubMed ID: 11106646
[TBL] [Abstract][Full Text] [Related]
5. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
[TBL] [Abstract][Full Text] [Related]
6. Insights into a single rod-like helix in activated radixin required for membrane-cytoskeletal cross-linking.
Hoeflich KP; Tsukita S; Hicks L; Kay CM; Tsukita S; Ikura M
Biochemistry; 2003 Oct; 42(40):11634-41. PubMed ID: 14529273
[TBL] [Abstract][Full Text] [Related]
7. Two Sides of the Coin: Ezrin/Radixin/Moesin and Merlin Control Membrane Structure and Contact Inhibition.
Michie KA; Bermeister A; Robertson NO; Goodchild SC; Curmi PMG
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018575
[TBL] [Abstract][Full Text] [Related]
8. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
[TBL] [Abstract][Full Text] [Related]
9. Self-masking in an intact ERM-merlin protein: an active role for the central alpha-helical domain.
Li Q; Nance MR; Kulikauskas R; Nyberg K; Fehon R; Karplus PA; Bretscher A; Tesmer JJ
J Mol Biol; 2007 Feb; 365(5):1446-59. PubMed ID: 17134719
[TBL] [Abstract][Full Text] [Related]
10. ERM-Merlin and EBP50 protein families in plasma membrane organization and function.
Bretscher A; Chambers D; Nguyen R; Reczek D
Annu Rev Cell Dev Biol; 2000; 16():113-43. PubMed ID: 11031232
[TBL] [Abstract][Full Text] [Related]
11. Janus kinases and focal adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains important for cell structure and signal transduction.
Girault JA; Labesse G; Mornon JP; Callebaut I
Mol Med; 1998 Dec; 4(12):751-69. PubMed ID: 9990861
[TBL] [Abstract][Full Text] [Related]
12. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
13. Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.
Yogesha SD; Sharff AJ; Giovannini M; Bricogne G; Izard T
Protein Sci; 2011 Dec; 20(12):2113-20. PubMed ID: 22012890
[TBL] [Abstract][Full Text] [Related]
14. The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product.
Kang BS; Cooper DR; Devedjiev Y; Derewenda U; Derewenda ZS
Acta Crystallogr D Biol Crystallogr; 2002 Mar; 58(Pt 3):381-91. PubMed ID: 11856822
[TBL] [Abstract][Full Text] [Related]
15. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.
Trofatter JA; MacCollin MM; Rutter JL; Murrell JR; Duyao MP; Parry DM; Eldridge R; Kley N; Menon AG; Pulaski K
Cell; 1993 Mar; 72(5):791-800. PubMed ID: 8453669
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
Sainio M; Zhao F; Heiska L; Turunen O; den Bakker M; Zwarthoff E; Lutchman M; Rouleau GA; Jääskeläinen J; Vaheri A; Carpén O
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2249-60. PubMed ID: 9378774
[TBL] [Abstract][Full Text] [Related]
17. Ezrin mutants affecting dimerization and activation.
Chambers DN; Bretscher A
Biochemistry; 2005 Mar; 44(10):3926-32. PubMed ID: 15751968
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.
Shimizu T; Seto A; Maita N; Hamada K; Tsukita S; Tsukita S; Hakoshima T
J Biol Chem; 2002 Mar; 277(12):10332-6. PubMed ID: 11756419
[TBL] [Abstract][Full Text] [Related]
19. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
20. Genomic structure of the human ezrin gene.
Majander-Nordenswan P; Sainio M; Turunen O; Jääskeläinen J; Carpén O; Kere J; Vaheri A
Hum Genet; 1998 Dec; 103(6):662-5. PubMed ID: 9921900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
